Michael Meyer

All Posts

  • Hedge Funds are Interested in Arena Pharmaceuticals

    By Michael Meyer - January 16, 2013 | Tickers: ARNA, OREX, VVUS

    One of the ways that retail investors can even out the flow of information is by following what hedge funds are investing in. A popular way to do this is to follow the 13F reports that hedge funds file each quarter. And while just blindly following what the big funds are buying is probably not the best idea, making this strategy one of your criteria for investing might be a more »

  • Is Now The Time To Invest In General Electric?

    By Michael Meyer - January 16, 2013 | Tickers: C, GE, SI

    When talking about General Electric (NYSE: GE), most people think about light bulbs. Yes the company does still make light bulbs, but they also do much more. They've become a truly diversified conglomerate with business operations in technology, financial services, and infrastructure. Because they are involved in so many businesses, they don't face industry risk as severely as some other, more focused companies might. If one industry does more »

  • 4 Reasons Dell Will Be Acquired

    By Michael Meyer - January 14, 2013 | Tickers: CAJ, DELL, BX

    Dell (NASDAQ: DELL) saw a huge move today on speculation that it has had several discussions with firms about a potential buyout.  The stock increased by 12.96% and is up an additional 3.5% in after-hours trading.  While most are still trying to wrap their heads around the possibility of a Dell takeout, I will list 4 reasons this makes sense for Dell.

    Reason #1 - Cheap Valuation

    Even after more »

  • 5 Reasons to Buy Microsoft Now

    By Michael Meyer - January 13, 2013 | Tickers: AMZN, AAPL, GOOG, IBM, MSFT, ORCL, SAP, VMW

    Microsoft (NASDAQ: MSFT) has long been thought of as a company that has already reached its peak.  With extremely low volatility levels and stable price moves, I can understand why investors may not be overly excited about investing in the company.  And while investors may no longer see doubles and triples in the stock price, Microsoft should still be considered as part of a diversified portfolio. Below are five reasons more »

  • 3 Stocks Being Bought by Hedge Funds

    By Michael Meyer - January 13, 2013 | Tickers: FB, GOOG, LNKD, YHOO

    One of the ways that retail investors can even out the flow of information is by following what hedge funds are investing in. A popular way to do this is to follow the 13F reports filed each quarter. And while just blindly following what the big funds are buying is probably not the best idea, adding it as one of your criteria might be a prudent move. Below are three more »

  • 6 Biotechnology Stocks With Upcoming Catalysts

    By Michael Meyer - January 11, 2013 | Tickers: ARNA, CELG, CLSN, DNDN, JNJ, SNY, THLD

    Biotechnology can be one of the most volatile industries to be invested in.  A lot of the time, investors can own shares in various companies and not even know there is an event coming up.  This article will serve to inform investors of 6 biotechnology stocks that have upcoming catalysts in 2013.  These catalysts are likely to have a significant impact upon each company.

    1) Celsion Corporation (NASDAQ: CLSN)

    Celsion more »

  • Apple: Is Selling Puts The Right Trade?

    By Michael Meyer - January 11, 2013 | Tickers: AAPL, GOOG

    Apple (NASDAQ: AAPL) is currently trading at $520.74, down 0.53% on the day.  The 30 day implied volatility is 39 which is up slight thus far in Friday's trading session.

    Apple has been on an incredible run over the past 52 weeks. It has gone from a low of 374.36 to a high of 701.86. It has had great earnings reports and also ones that more »

  • Brazil's Future Looks Promising

    By Michael Meyer - January 11, 2013 | Tickers: VALE, EWZ, PBR

    Investors are always looking for the next big idea.  Although the U.S. recently avoided a fiscal cliff, there are still a lot of challenges ahead.  In light of those challenges, investors may want to consider an emerging market that appears poised for a bright future.  That market is Brazil.

    Although Brazil has had its struggles of late, there are many reasons that investors should still be optimistic about the more »

  • Google Options Overpriced For Earnings

    By Michael Meyer - January 11, 2013 | Tickers: GOOG

    Earnings season occurs four times a year and it can be one of the most rewarding but also dangerous times for investors. Only those with a keen sense of risk versus reward can continue to realize success from earnings trades. But more than just proper risk management, the proper strategy must be used as well. And by using options, one can trade earnings the same way that professional volatility traders more »

  • Celldex May Soar in 2013

    By Michael Meyer - January 10, 2013 | Tickers: CLDX, SGEN

    With so many companies claiming to have found the miracle cure for all diseases, it can be a tough challenge to find the contenders instead of the pretenders.  But there is one company that appears to be getting closer to find the illusive treatment for breast cancer.  That company is Celldex Therapeutics (NASDAQ: CLDX).

    Celldex Therapeutics is a biopharmaceutical company focused on the development, manufacture, and commercialization of novel therapeutics more »

  • Initial Public Offerings Are A Bad Investment

    By Michael Meyer - January 9, 2013 | Tickers: FB, GRPN, LNKD, ZNGA | Editor's Choice

    Initial Public Offerings, better known as IPOs, have been known to make investor riches. The only problem is, the riches usually go to the investors who got in before public trading started. Only the wealthiest and most connected investors have access to pre-IPO prices. And unfortunately, that leaves out most people reading this article. Since before the Dot Com bubble, it seemed like there were stories coming out every day more »

  • 3 Dividend Stocks To Consider

    By Michael Meyer - January 4, 2013 | Tickers: NLY, ORAN, PBI

    Editor's Note: The original article referenced a 10% yield for FTE. Upon further inspection, the company is shooting for an $0.80 payout. The dividend yield and price have been updated.

    With the current uncertainty in the market, having a solid list of dividend stocks in your portfolio is a must. Not only do they provide a constant stream of income, they also are generally solid businesses with low more »